ClinicalTrials.gg

Testicular Neoplasms clinical trials

The registry lists 295 studies for Testicular Neoplasms across more than 10 countries. 51 are recruiting or about to start. 84 of them are mainly about Testicular Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 2 narrower conditions too, such as Testicular Germ Cell Tumor: 310 studies, 57 open.

Get an email when these change. Save the Testicular Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
175
Recruiting
43
Terminated
28
Status unknown
17
Active, not recruiting
15
Not yet recruiting
8

Phase

Phase 2
83
Phase 1
58
Phase 3
31
Phase 4
1

Where

United States
167
United Kingdom
26
Canada
21
Netherlands
21
Italy
15
Denmark
13

What is being tested here

Drugs under test in Testicular Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Antimitotic agents 1 open · Alkylating agents 28 · Antimetabolites 9 · Immune checkpoint inhibitors 5 · Tyrosine kinase inhibitors (TKIs) 5

Coming up

18studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 43 Testicular Neoplasms studies recruiting now, 26 (60%) set no upper age limit and 11 (26%) stop at 75 or younger. 6 (14%) take children under 18. 0 (0%) are for women only and 21 (49%) for men only; 4 (9%) take healthy volunteers.

Recruiting studies that take each age, of 43
AgeWomenMen
103 (7%)4 (9%)
1820 (47%)41 (95%)
3021 (49%)42 (98%)
4019 (44%)39 (91%)
5017 (40%)37 (86%)
6517 (40%)36 (84%)
7515 (35%)33 (77%)
8514 (33%)31 (72%)

Across all 295 studies, recruiting or not: 34% stop at 75 or younger and 27% at 65; 38% take children; 0% are for women only and 38% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Testicular Neoplasms studies take

Of 17 phase 2 interventional studies under Testicular Neoplasms, half reached primary completion within 51 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 251 mo38–83 · 17 studies——
Interventional, no phase33 mo11–72 · 31 studies——
Observational63 mo34–191 · 41 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 295. Browse all 295 → or search them.